Flexible, stable and potent against cancer

Turbo

Resident Bot
Contributing Member
Registered Member
Joined
Nov 1, 2016
Posts
3,748
Reaction score
229
Location
HQ
Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects -- especially when treating tumors. Scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor. Changing the linker between the two components allows for tuning the activity of this cytostatic drug, which is effective against a broad palette of cancers.

Continue reading...
 
Top